Today: 11 March 2026

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

SpaceX’s $400 Billion Moonshot: How to Invest in Elon Musk’s Rocket Empire in 2025

SpaceX’s $400 Billion Moonshot: How to Invest in Elon Musk’s Rocket Empire in 2025

SpaceX remains private in 2025, with a valuation near $400 billion after secondary share talks. Elon Musk holds about 42% ownership; major investors include Alphabet, Fidelity, and top venture firms. No IPO is planned, but a Starlink spin-off is possible by 2026. In September 2025, SpaceX agreed to buy $17 billion in wireless spectrum from EchoStar to expand its direct-to-cell service.
AI Models Are Scheming – Inside OpenAI’s Plan to Stop Deceptive AI Behavior

How to Invest in OpenAI in 2025: All the Ways to Own a Stake in ChatGPT’s Creator

A secondary share sale in October 2025 valued OpenAI at $500 billion, making it the world’s most valuable startup. OpenAI remains private, with no public stock available. Microsoft, SoftBank, and NVIDIA hold major stakes, offering indirect exposure through their shares. The ARK Venture Fund also gives retail investors partial access to OpenAI’s growth.
Advance Agrolife IPO Frenzy: 50x Subscription on Final Day, ₹115 Grey Market Listing & 15% Gains Expected

Advance Agrolife IPO Frenzy: 50x Subscription on Final Day, ₹115 Grey Market Listing & 15% Gains Expected

Advance Agrolife’s ₹192.86 crore IPO closed October 3 after being oversubscribed nearly 55 times, with non-institutional bids at 174 times. Shares are expected to list October 8 on BSE and NSE. Unofficial grey market trades value the stock at ₹115, a 15% premium over the ₹100 issue price. The Jaipur-based agrochemical maker reported FY25 revenue of ₹502 crore and profit of ₹25.6 crore.
3 October 2025
Iran’s Rial Crisis Deepens: USD Soars Past 1.08 Million on Black Market Amid Sanctions Fears (قیمت دلار)

Sanctions Send Iran’s Rial Tumbling – Dollar Skyrockets to 1.1 Million on the Black Market (قیمت دلار)

The Iranian rial fell to a record low in late 2025, with one U.S. dollar trading for IRR 1,080,000–1,130,000 on the open market. The Central Bank’s official rate remained near IRR 545,700 per dollar in April. Sanctions and fears of renewed restrictions fueled the slide, while most foreign trade now relies on shadow networks and informal money channels.
3 October 2025
Planet Labs (PL) Stock Skyrockets on Record Earnings, SpaceX Launch & Major Contracts

Planet Labs (PL) Stock Skyrockets on Record Earnings, SpaceX Launch & Major Contracts

Planet Labs (NYSE: PL) traded near $14.60 on Oct. 2, 2025, up 6% for the day and 250% year-to-date, hitting a 52-week high after strong Q2 results and new contracts. Q2 revenue reached $73.4 million, up 20% YoY, with adjusted EBITDA at $6.4 million profit and backlog surging 516% to $690 million. The company launched new satellites and signed major deals, including a €240 million contract with Germany. Analyst ratings remain broadly positive.
Joby Aviation Stock Skyrockets on Game-Changing Deals & FAA Push (Oct 2025)

Joby Aviation Stock Skyrockets on Game-Changing Deals & FAA Push (Oct 2025)

Joby shares closed at $17.10 on Oct. 2, up 5.5%, after tripling in the past year. The company acquired Blade Air Mobility’s passenger business for up to $125 million and flew its eVTOL publicly at Japan’s Expo 2025. Q2 revenue was about $20,000 with a $325 million net loss; cash on hand was $991 million. Most analysts rate the stock “Hold,” with an average price target of $10.50.
Oklo (OKLO) Nuclear Stock Skyrockets 500% on AI Data Center Hype – Bubble or Breakthrough?

Oklo (OKLO): Nuclear Power’s New Heavyweight – DOE Contracts, $1.68B Fuel Plant & 400% Rally

Oklo (NYSE: OKLO), a Santa Clara-based advanced nuclear developer chaired by Sam Altman, surged over 400% in 2025, reaching a $17B market cap after major DOE awards and nuclear/AI momentum. The company, which went public via SPAC in May 2024, has no revenue and is not expected to be profitable in 2025. Analyst targets range from $88 to $146, with consensus at “Moderate Buy.”
Astera Labs Stock Soars on AI Momentum: Is This High-Flying Chip Innovator Still a Buy in 2025?

Astera Labs Stock Soars on AI Momentum: Is This High-Flying Chip Innovator Still a Buy in 2025?

Astera Labs shares surged nearly 286% since its March 2024 IPO, hitting a high of $262.90 in September 2025 before retreating to $195 on Oct. 2. Fiscal Q2 2025 revenue jumped 150% year-over-year to $191.9 million, with net income of $51.2 million. Hedge fund FengHe Fund Management became the largest shareholder in October. Analysts remain bullish but warn of stretched valuations and volatility.
Is WeRide’s Robotaxi Revolution About to Change the World? A Deep Dive into WRD as of Oct‑2‑2025

Is WeRide’s Robotaxi Revolution About to Change the World? A Deep Dive into WRD as of Oct‑2‑2025

WeRide Inc. reported Q2 2025 revenue of $17.8 million, up 60.8% year-on-year, but posted a net loss of $338.7 million over the past 12 months. WRD shares rose about 7–8% on October 2 after launching robotaxi pilots in the UAE, but remain down over 27% year-to-date. The company claims a fleet of 1,300+ autonomous vehicles in 30+ cities. Four analysts rate the stock “Strong Buy” with a $17.88 target.
Cipher Mining (CIFR) Skyrockets on Google-Backed AI Deal & Bitcoin Boom – What to Know Now

Cipher Mining’s Bold Pivot: Can CIFR’s AI-Powered Future Sustain the Rally?

Cipher Mining (CIFR) closed at $12.59 on Oct. 2, with volume surging to 61 million shares. The company announced a 10-year HPC colocation deal with Fluidstack, backed by Google, potentially worth up to $7 billion. Cipher also priced a $1.1 billion zero-coupon convertible note and reported a Q2 net loss of $45.8 million on $43.6 million revenue. Analyst upgrades followed, but JonesResearch maintained a Hold rating.
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

Quantum Leap for Investors: D-Wave (QBTS) Stock Rockets Amid Breakthroughs, Big Cash & Booming Demand

QBTS closed up 11.5% at $28.57 on Oct 2, 2025, with nearly 19.8 million shares traded, nearing its 12-month high. The stock has surged from the mid-$18s since mid-September. D-Wave reported $3.1 million in Q2 revenue and ended the quarter with $819 million in cash after a $400 million share offering. Wall Street consensus remains “Buy,” with average 12-month targets of $20–23.
SoundHound AI Stock Skyrockets on Red Lobster Deal – Is SOUN the Next Big AI Winner or Overhyped?

SoundHound AI (SOUN) Stock Soars on AI Hype: 217% Growth, Major Deals & Can It Topple the Tech Giants?

SoundHound AI shares closed near $17 on Oct. 2, 2025, up about 5% with a market cap around $6.6 billion. Q2 revenue hit a record $42.7 million, up 217% year-over-year, while management raised full-year guidance. In September, SoundHound acquired Interactions and announced deals with Red Lobster and Primary Health Solutions. Short interest stands at roughly 30% of float amid strong retail buzz.
Rigetti Computing’s Quantum Leap: Stock Soars on Breakthroughs and Bold Bets

Rigetti (RGTI) Stock Soars on New Quantum Wins — Breakthrough or Bubble?

Rigetti shares surged about 160% over three months, hitting a 52-week high near $34.40 in late September. The company announced $5.7 million in QPU orders and a $5.8 million Air Force contract, and rolled out a 36-qubit processor. Q2 revenue fell 42% year-over-year to $1.8 million, with a $39.7 million net loss. Most analysts rate the stock a buy, but average targets sit well below current prices.
Sky Is No Limit: Global Satcom Market Set to Soar Through 2035

AST SpaceMobile (ASTS) Stock Skyrockets on New Satellite and Carrier Milestones – Record Highs and $60+ Targets

AST SpaceMobile (NASDAQ: ASTS) hit an all-time high near $61.18 on Oct. 2, 2025, after surging 130% YTD and trading over $1 billion in volume on Oct. 1. The company, valued near $21.6 billion, has secured major carrier deals including Bell Canada and Vodafone, and holds agreements with over 50 mobile operators. ASTS is building large BlueBird satellites, with launches planned every 1–2 months through 2026. Q2 2025 revenue was $1.15 million, with EPS at –$0.41.
Tesla Model 3 vs BYD Seal vs Hyundai Ioniq 6: The Ultimate 2025 EV Showdown—Which One Should You Buy?

Tesla’s Meteoric Momentum: Why Oct. 2, 2025 Could Be a Game‑Changer for TSLA Investors

Tesla closed at $459 on Oct. 2, 2025, down 2.38% from the prior day, with 36 million shares traded. The company delivered 497,099 vehicles in Q3, beating analyst estimates by about 50,000 as buyers rushed to claim expiring U.S. tax credits. Market cap stood at $1.53 trillion, ranking Tesla ninth globally. The P/E ratio reached 243, far above industry averages.
Coinbase (COIN) Stock Crashes in Crypto Sell-Off – Can It Bounce Back?

Coinbase Stock Rally: Performance, News and Regulatory Landscape as of Oct 2 2025

Coinbase Global Inc. traded at $363.70 on Oct. 2, 2025, up 5.06% from the previous close. The company reported Q2 net revenue of $1.42 billion and net income of $1.43 billion, with a 40.87% net margin. A New Jersey judge allowed a shareholder lawsuit over SEC risk disclosures to proceed. The SEC dropped its enforcement action in February, citing a shift in regulatory approach.
Ondas Holdings Skyrockets into the U.S. Defense Drone Race – Is ONDS the Next Tech Titan?

Ondas Holdings Skyrockets into the U.S. Defense Drone Race – Is ONDS the Next Tech Titan?

Ondas Holdings (NASDAQ: ONDS) shares surged 460% year-over-year, hitting a 52-week high of $8.58 on Sept. 29, 2025, after major defense orders and a $200M share offering. Q2 revenue reached a record $6.3M, with a net loss of $10.8M. Ondas acquired Apeiro Motion for $12M and took a 51% stake in SPO Smart Precision Optics. Cash on hand stood at $68.6M as of June 30.
Sarepta Therapeutics (SRPT) Surges After FDA Greenlights Duchenne Gene Therapy – Is a Rebound Ahead?

Sarepta Therapeutics (SRPT) Surges After FDA Greenlights Duchenne Gene Therapy – Is a Rebound Ahead?

SRPT closed at $19.57 on Oct 2, up 6.8% for the day and nearly 16% over the past month, but remains down about 82% year-to-date. The company restructured in July, cutting 500 jobs and pausing some gene therapy trials after FDA safety concerns. Sarepta resumed shipments of Elevidys for ambulatory DMD patients following FDA guidance. Analyst consensus is “Hold,” with price targets ranging from $14 to $39.
Rivian’s $5 Billion Georgia EV Megaplant: A Bold Gamble to Outdrive Tesla, Ford & More

Will Rivian’s Stock Rebound or Crash? October 2025 Deep Dive into RIVN and the EV Industry

Rivian shares fell about 7% to $13.57 on Oct. 2, 2025, after the company cut its 2025 delivery guidance to 41,500–43,500 vehicles. Rivian produced 10,720 vehicles and delivered 13,201 in Q3. The company posted its first positive gross profit of $206 million in early 2025. A $5.8 billion joint venture with Volkswagen was announced to develop new EV technology.
Tawana Resources (TAWNF) 2025 Stock Skyrocket: Lithium Revival or Mirage?

USA Rare Earth (USAR) Stock Soars on $100M Deal – Is the Rally Sustainable?

USA Rare Earth shares hit a record $20.02 on Oct. 2, 2025, after announcing a $100 million cash-and-stock acquisition of UK-based Less Common Metals and a $125 million PIPE financing. Barbara Humpton took over as CEO Oct. 1. USAR reported no revenues but held $128 million in cash and no significant debt as of August. The stock is up about 170% in six months, fueled by the LCM deal and rare-earth sector momentum.
2 October 2025
1 261 262 263 264 265 358
Go toTop